DUNAD Trademark

Trademark Overview


On Friday, June 26, 2020, a trademark application was filed for DUNAD with the United States Patent and Trademark Office. The USPTO has given the DUNAD trademark a serial number of 90022032. The federal status of this trademark filing is REGISTERED as of Tuesday, November 2, 2021. This trademark is owned by Warhead Ltd. The DUNAD trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

pharmaceutical preparations for pain, cancer, autoimmune disease, inflammatory disease, neurological disease, psychiatric disease, cardiovascular disease, metabolic disease, endocrine disease, musculoskeletal disease, genetic disease, gastrointestinal disease, haematological disease, respiratory disease, infectious disease, ophthalmological disease, renal disease, hepatic disease, urological disease, gynaecological disease, dermatological disease; Medical preparations for pain, cancer, autoimmune disease, inflammatory disease, neurological disease, psychiatric disease, cardiovascular disease, metabolic disease, endocrine disease, musculoskeletal disease, genetic disease, gastrointestinal disease, haematological disease, respiratory disease, infectious disease, ophthalmological disease, renal disease, hepatic disease, urological disease, gynaecological disease, dermatological disease; Veterinary preparations for cats, dogs, pets, livestock

scientific research in the pharmaceutical field; pharmaceutical research and development services; providing scientific research information in the field of pharmaceutical research and development
dunad

General Information


Serial Number90022032
Word MarkDUNAD
Filing DateFriday, June 26, 2020
Status700 - REGISTERED
Status DateTuesday, November 2, 2021
Registration Number6542240
Registration DateTuesday, November 2, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 17, 2021

Trademark Statements


Goods and Servicespharmaceutical preparations for pain, cancer, autoimmune disease, inflammatory disease, neurological disease, psychiatric disease, cardiovascular disease, metabolic disease, endocrine disease, musculoskeletal disease, genetic disease, gastrointestinal disease, haematological disease, respiratory disease, infectious disease, ophthalmological disease, renal disease, hepatic disease, urological disease, gynaecological disease, dermatological disease; Medical preparations for pain, cancer, autoimmune disease, inflammatory disease, neurological disease, psychiatric disease, cardiovascular disease, metabolic disease, endocrine disease, musculoskeletal disease, genetic disease, gastrointestinal disease, haematological disease, respiratory disease, infectious disease, ophthalmological disease, renal disease, hepatic disease, urological disease, gynaecological disease, dermatological disease; Veterinary preparations for cats, dogs, pets, livestock
Goods and Servicesscientific research in the pharmaceutical field; pharmaceutical research and development services; providing scientific research information in the field of pharmaceutical research and development

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, July 23, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, July 23, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameDUNAD THERAPEUTICS LTD
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressCAMBRIDGE CB23 6HJ

Party NameDUNAD THERAPEUTICS LTD
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressCAMBRIDGE CB23 6HJ

Party NameDUNAD THERAPEUTICS LTD
Party Type11 - New Owner Before Publication
Legal Entity Type16 - Limited Liability Company
AddressCAMBRIDGE CB23 6HJ

Party NameWarhead Ltd
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressLondon EC2N1AR
GB

Trademark Events


Event DateEvent Description
Tuesday, November 2, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, August 17, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 17, 2021PUBLISHED FOR OPPOSITION
Wednesday, July 28, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, July 15, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 23, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 23, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, June 23, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, April 2, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, April 2, 2021NON-FINAL ACTION E-MAILED
Friday, April 2, 2021NON-FINAL ACTION WRITTEN
Monday, March 8, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 8, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 4, 2021ASSIGNED TO LIE
Thursday, February 25, 2021TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, January 27, 2021AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, November 30, 2020NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, November 30, 2020LETTER OF SUSPENSION E-MAILED
Monday, November 30, 2020SUSPENSION LETTER WRITTEN
Tuesday, November 24, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, November 24, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, November 19, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, October 5, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, October 5, 2020NON-FINAL ACTION E-MAILED
Monday, October 5, 2020NON-FINAL ACTION WRITTEN
Tuesday, September 29, 2020ASSIGNED TO EXAMINER
Thursday, July 23, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, July 23, 2020PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Tuesday, July 14, 2020ASSIGNED TO LIE
Thursday, July 2, 2020TEAS VOLUNTARY AMENDMENT RECEIVED
Tuesday, June 30, 2020NEW APPLICATION ENTERED IN TRAM